| |
| |
|
| Insider
Information: |
Kirske David |
| Relationship: |
EVP, Chief Financial O... |
| City: |
Seattle |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cti Biopharma Corporation |
CTIC |
EVP, Chief Financial O... |
2023-06-26 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Financial Officer |
• – – |
2023-06-26 |
4 |
D |
$9.10 |
$159,678 |
D/D |
(17,547) |
0 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Financial Officer |
• – – |
2023-01-03 |
4 |
AS |
$6.01 |
$162,423 |
D/D |
(27,021) |
17,127 |
0 |
% |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Financial Officer |
• – – |
2023-01-03 |
4 |
OE |
$0.95 |
$25,640 |
D/D |
27,021 |
44,148 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Financial Officer |
• – – |
2022-12-30 |
4 |
AS |
$6.00 |
$83,096 |
D/D |
(13,847) |
17,127 |
0 |
% |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Financial Officer |
• – – |
2022-12-30 |
4 |
OE |
$0.95 |
$13,139 |
D/D |
13,847 |
18,174 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Financial Officer |
• – – |
2022-12-30 |
4 |
A |
$5.11 |
$1,093 |
D/D |
214 |
17,127 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Financial Officer |
• – – |
2022-12-29 |
4 |
OE |
$0.95 |
$12,501 |
D/D |
13,174 |
30,087 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Financial Officer |
• – – |
2022-12-29 |
4 |
AS |
$6.00 |
$79,044 |
D/D |
(13,174) |
16,913 |
0 |
% |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Financial Officer |
• – – |
2022-10-04 |
4 |
AS |
$6.25 |
$13,194 |
D/D |
(2,109) |
16,913 |
0 |
% |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Financial Officer |
• – – |
2022-10-04 |
4 |
OE |
$0.95 |
$2,001 |
D/D |
2,109 |
17,522 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Financial Officer |
• – – |
2022-10-03 |
4 |
AS |
$6.25 |
$1,875 |
D/D |
(300) |
16,913 |
0 |
% |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Financial Officer |
• – – |
2022-10-03 |
4 |
OE |
$0.95 |
$285 |
D/D |
300 |
17,213 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Financial Officer |
• – – |
2022-09-30 |
4 |
AS |
$6.05 |
$845,549 |
D/D |
(139,841) |
16,913 |
0 |
% |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Financial Officer |
• – – |
2022-09-30 |
4 |
OE |
$0.95 |
$132,695 |
D/D |
139,841 |
156,754 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Financial Officer |
• – – |
2022-09-29 |
4 |
AS |
$6.00 |
$5,401 |
D/D |
(900) |
16,913 |
0 |
% |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Financial Officer |
• – – |
2022-09-29 |
4 |
OE |
$0.95 |
$854 |
D/D |
900 |
17,013 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Financial Officer |
• – – |
2022-09-16 |
4 |
AS |
$6.02 |
$136,004 |
D/D |
(22,592) |
16,913 |
0 |
% |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Financial Officer |
• – – |
2022-09-16 |
4 |
OE |
$0.95 |
$21,438 |
D/D |
22,592 |
39,505 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Financial Officer |
• – – |
2022-06-30 |
4 |
A |
$2.12 |
$20,141 |
D/D |
9,516 |
16,913 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Financial Officer |
• – – |
2022-06-17 |
4 |
OE |
$1.00 |
$175,000 |
D/D |
60,000 |
57,397 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Financial Officer |
• – – |
2022-06-17 |
4 |
AS |
$6.00 |
$372,505 |
D/D |
(60,000) |
7,397 |
0 |
% |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Financial Officer |
• – – |
2022-06-14 |
4 |
OE |
$0.95 |
$9,489 |
D/D |
10,000 |
17,397 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Financial Officer |
• – – |
2022-06-14 |
4 |
AS |
$5.50 |
$55,000 |
D/D |
(10,000) |
7,397 |
0 |
% |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Financial Officer |
• – – |
2021-12-31 |
4 |
A |
$2.11 |
$3,830 |
D/D |
1,817 |
7,397 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Financial Officer |
• – – |
2021-06-30 |
4 |
A |
$2.13 |
$3,787 |
D/D |
1,782 |
5,580 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
